1Sugiura K, Hiramoto K, Shamoto M, et al. Immunological cell situation in the skin of atopic model mice. J Eur Acad Derm Venereol 2004; 18(2) : 148 - 152.
2Michael R, Ardem J, Antony P, et al. Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells. Natl Acad Sci 2007; 104(13) :5557 - 5562.
3Dhafer L, Harri A, Paul B, et al. IL - 10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003 ; 112(7) : 1058 - 1066.
4Howell MD, Novak N, Bieber T, et al. Interleukin- 10 downregulates anti - microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005; 125(4) :738 - 745.
5Obara W, Kawa Y, Ra C, et al. T cells and mast cells as a majorsource of interleukin- 13 in atopic dermatitis. Dermatology 2002; 205(1):11- 17.
6Metwally SS, Mosaad YM, Abdel- Samee ER, et al. IL- 13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity. Egypt J Immunol 2004;11(2):171 - 177.
7Lehmann HS, Heaton T, Mallon D, et al. Staphylococcal enterotox- in - B - mediated stimulation of interleukin - 13 production as a po- tential aetiologic factor in eczema in infants. Int Arch Allergy Immunol 2004; 135(4) :306 - 312.
8Takaoka A, Arai I, Suqirnoto M, at al. Expression of IL- 31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2005;516(2) : 180 - 181.
9Sonkoly E, Muller A, Lauerma AI, et al. IL- 31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2005;117(2) :411 -417.
10Yawalkar N, Karlen S, Egli F, et al. Down - regulation of IL- 12 by topical corticosteroids in chronic atopic dermatitis. J Allergy Clin lmmunol 2000; 106(5) :941 - 947.
